Titles and Roles
- Professor, Department of Hematology and Medical Oncology
- Emory University School of Medicine
- Research Program
- Cancer Cell Biology
A Georgia Cancer Coalition Distinguished Cancer Scholar, Shi-Yong Sun, PhD, is a tenured Professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. Dr. Sun started his faculty career in 1999 and joined Emory in 2003.
Dr. Sun is a member of the Cancer Cell Biology Research Program at Winship Cancer Institute. He is also an active member of the American Association for Cancer Research.
Dr. Sun earned his PhD in cancer pharmacology at Peking Union Medical College/Chinese Academy of Medical Sciences in China in 1990 and received his postdoctoral training in cancer biology at the University of Texas M.D. Anderson Cancer Center in Houston, Texas.
The long-term goal of Dr. Sun's lab is to identify and develop novel and efficacious therapeutic agents or regimens to treat cancer through fully understanding the biology of cancer, particularly pathways that support the survival and growth of cancer cells. His lab primarily focuses on studying regulation of death receptors, particularly TRAIL receptors, by small cancer therapeutic molecules and their implications in drug-induced apoptosis and cancer therapy. His lab is also interested in Akt/mTOR signaling and in targeting this signaling pathway for cancer therapy.
Dr. Sun is on the editorial boards of 12 cancer-related journals and has published extensively in prominent peer-reviewed journals.
Publications Publication Date
Dr. Sun is a recipient of numerous peer-reviewed grant awards including NIH/NCI R01, P01 and SPORE. Additionally, he is the recipient of the Georgia Cancer Coalition Distinguished Cancer Scholar (2003-2008). In 2015, he was named to the MilliPub Club, which recognizes current Emory faculty who have published one or more individual papers throughout their careers that have garnered more than 1,000 citations.